Nexalin Technology Appoints Carmi Masha Technologies Ltd. as Exclusive Distributor in Israel November 13, 2025
Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia November 5, 2025
Nexalin Technology Announces Regulatory Approval to Sell Gen 2 SYNC, 15 mA Neurostimulation DIFS™ Device in Israel October 30, 2025
